CIK 1643354
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 96.48% | 32 |
| Unclassified | 2.29% | 2 |
| Machinery | 1.22% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 8.57% |
| 2 | MLTX | MoonLake Immunotherapeutics | Health Care | 7.52% |
| 3 | RPRX | Royalty Pharma plc | Health Care | 6.14% |
| 4 | MIST | Milestone Pharmaceuticals Inc. | Health Care | 5.83% |
| 5 | GERN | GERON CORP | Health Care | 5.15% |
| 6 | SNDX | Syndax Pharmaceuticals Inc | Health Care | 5.03% |
| 7 | ARDX | ARDELYX, INC. | Health Care | 4.61% |
| 8 | FENC | FENNEC PHARMACEUTICALS INC. | Health Care | 4.13% |
| 9 | BNTC | Benitec Biopharma Inc. | Health Care | 3.95% |
| 10 | SRPT | Sarepta Therapeutics, Inc. | Health Care | 3.71% |
33/35 names classified · sector 97.7% of weight · industry 97.7% · mkt cap 97.1%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 97.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 8% of book weight classified — the grid is NOT representative of the whole book.
Classified: 8.4% of book weight (5/35 names) · unclassified 91.6%: PRAX, MLTX, RPRX, MIST, GERN, SNDX, ARDX, FENC, BNTC, SRPT +20 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | 4,450 | $1M | 8.6% | HOLD |
| 2 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 67,500 | $1M | 7.5% | HOLD |
| 3 | RPRXROYALTY PHARMA PLC | 21,400 | $1M | 6.1% | HOLD |
| 4 | MISTMILESTONE PHARMACEUTICALS IN | 820,000 | $975,800 | 5.8% | ADD 9% |
| 5 | GERNGERON CORP | 578,000 | $861,220 | 5.1% | HOLD |
| 6 | SNDXSYNDAX PHARMACEUTICALS INC | 36,000 | $840,960 | 5.0% | HOLD |
| 7 | ARDXARDELYX INC | 128,650 | $770,614 | 4.6% | HOLD |
| 8 | FENCFENNEC PHARMACEUTICALS INC | 112,434 | $691,469 | 4.1% | HOLD |
| 9 | BNTCBENITEC BIOPHARMA INC | 62,000 | $660,300 | 3.9% | HOLD |
| 10 | SRPTSAREPTA THERAPEUTICS INC | 28,500 | $620,160 | 3.7% | HOLD |
| 11 | IRONDISC MEDICINE INC | 8,100 | $517,914 | 3.1% | HOLD |
| 12 | CUECUE BIOPHARMA INC | 2,202,854 | $506,436 | 3.0% | HOLD |
| 13 | CMPSCOMPASS PATHWAYS PLC | 80,000 | $442,400 | 2.6% | ADD 38% |
| 14 | BHVNBIOHAVEN LTD | 51,700 | $437,382 | 2.6% | HOLD |
| 15 | LNTHLANTHEUS HLDGS INC | 5,500 | $417,175 | 2.5% | HOLD |
| 16 | JSPRJASPER THERAPEUTICS INC | 465,000 | $407,433 | 2.4% | HOLD |
| 17 | HUMAHUMACYTE INC | 650,000 | $394,355 | 2.4% | ADD 30% |
| 18 | VTRSVIATRIS INC | 27,700 | $374,227 | 2.2% | HOLD |
| 19 | KURAKURA ONCOLOGY INC | 46,000 | $373,980 | 2.2% | HOLD |
| 20 | BBIOBRIDGEBIO PHARMA INC | 5,000 | $371,300 | 2.2% | HOLD |
| 21 | DYNDYNE THERAPEUTICS INC | 18,000 | $326,340 | 2.0% | HOLD |
| 22 | RCKTROCKET PHARMACEUTICALS INC | 86,000 | $307,880 | 1.8% | HOLD |
| 23 | PCRXPACIRA BIOSCIENCES INC | 13,500 | $305,100 | 1.8% | HOLD |
| 24 | EWTXEDGEWISE THERAPEUTICS INC | 9,100 | $286,650 | 1.7% | HOLD |
| 25 | MLYSMINERALYS THERAPEUTICS INC | 10,500 | $284,445 | 1.7% | HOLD |
| 26 | MCRBSERES THERAPEUTICS INC | 31,570 | $280,026 | 1.7% | HOLD |
| 27 | JANXJANUX THERAPEUTICS INC | 19,000 | $264,100 | 1.6% | HOLD |
| 28 | QUREUNIQURE NV | 14,700 | $240,345 | 1.4% | HOLD |
| 29 | RGNXREGENXBIO INC | 26,600 | $222,908 | 1.3% | HOLD |
| 30 | AZTAAZENTA INC | 9,700 | $204,961 | 1.2% | HOLD |
| 31 | INVAINNOVIVA INC | 8,200 | $191,060 | 1.1% | HOLD |
| 32 | GHRSGH RESEARCH PLC | 10,200 | $143,412 | 0.9% | HOLD |
| 33 | ARQTARCUTIS BIOTHERAPEUTICS INC | 5,250 | $123,690 | 0.7% | HOLD |
| 34 | IPHAINNATE PHARMA S A | 81,151 | $103,873 | 0.6% | HOLD |
| 35 | SPRBSPRUCE BIOSCIENCES INC | 1,000 | $65,350 | 0.4% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| PRAXPRAXIS PRECISION MEDICINES I | — | — | — | 6K | 4K | 4K | $1M |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | — | — | — | 68K | 68K | 68K | $1M |
| RPRXROYALTY PHARMA PLC | — | — | — | 21K | 21K | 21K | $1M |
| MISTMILESTONE PHARMACEUTICALS IN | 1.0M | 549K | 549K | 659K | 755K | 820K | $975,800 |
| GERNGERON CORP | 500K | 500K | 500K | 500K | 578K | 578K | $861,220 |
| SNDXSYNDAX PHARMACEUTICALS INC | 55K | 55K | 55K | 55K | 36K | 36K | $840,960 |
| ARDXARDELYX INC | 335K | 335K | 335K | 163K | 129K | 129K | $770,614 |
| FENCFENNEC PHARMACEUTICALS INC | 196K | 196K | 196K | 123K | 112K | 112K | $691,469 |
| BNTCBENITEC BIOPHARMA INC | 62K | 62K | 62K | 62K | 62K | 62K | $660,300 |
| SRPTSAREPTA THERAPEUTICS INC | — | — | — | — | 29K | 29K | $620,160 |
| IRONDISC MEDICINE INC | 11K | 11K | 11K | 11K | 8K | 8K | $517,914 |
| CUECUE BIOPHARMA INC | — | — | — | — | 2.2M | 2.2M | $506,436 |
| CMPSCOMPASS PATHWAYS PLC | — | — | — | 58K | 58K | 80K | $442,400 |
| BHVNBIOHAVEN LTD | 23K | 23K | 23K | 23K | 52K | 52K | $437,382 |
| LNTHLANTHEUS HLDGS INC | — | — | — | — | 6K | 6K | $417,175 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
